TWI705830B - Anhydrous powder type cosmetic composition - Google Patents

Anhydrous powder type cosmetic composition Download PDF

Info

Publication number
TWI705830B
TWI705830B TW105120624A TW105120624A TWI705830B TW I705830 B TWI705830 B TW I705830B TW 105120624 A TW105120624 A TW 105120624A TW 105120624 A TW105120624 A TW 105120624A TW I705830 B TWI705830 B TW I705830B
Authority
TW
Taiwan
Prior art keywords
silicone
polydimethylsiloxane
weight
powder
composition
Prior art date
Application number
TW105120624A
Other languages
Chinese (zh)
Other versions
TW201707681A (en
Inventor
薑弦月
薑愉珍
金京南
崔庚浩
崔榮鎭
Original Assignee
愛茉莉太平洋股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 愛茉莉太平洋股份有限公司 filed Critical 愛茉莉太平洋股份有限公司
Publication of TW201707681A publication Critical patent/TW201707681A/en
Application granted granted Critical
Publication of TWI705830B publication Critical patent/TWI705830B/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/895Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

本發明提供一種無水粉末劑型化妝品組合物。所述組合物包括矽彈性體凝膠;包含聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物‧二氧化矽的矽彈性體粉末;包含乙烯基聚二甲基矽氧烷/聚甲基矽氧烷矽倍半氧烷交聯聚合物的矽樹脂粉末;矽油;以及矽凝膠劑。 The present invention provides an anhydrous powder dosage type cosmetic composition. The composition includes silicone elastomer gel; silicone elastomer powder containing polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer‧silicon dioxide; containing vinyl polydimethylsiloxane Silicone resin powder of silicone/polymethylsiloxane silsesquioxane cross-linked polymer; silicone oil; and silicone gel agent.

Description

無水粉末劑型化妝品組合物 Anhydrous powder type cosmetic composition

本發明提供一種無水粉末劑型化妝品組合物。 The present invention provides an anhydrous powder dosage type cosmetic composition.

本申請要求於2015年6月30日向韓國專利局提交的韓國專利申請第10-2015-0093767號的申請日的利益,其全部內容包含於本說明書中。 This application claims the benefit of the filing date of Korean Patent Application No. 10-2015-0093767, which was filed with the Korean Patent Office on June 30, 2015, and the entire contents of which are included in this specification.

對於含有粉末的化妝品,當適用於皮膚時,起到改善膚色,並且防止毛孔、皺紋、皮膚問題等的同時,將肌膚加強至均勻的狀態等的作用。這種含有粉末的化妝品可以製備成多種劑型,在乳化劑型的情況下,由於使用於均勻地分散油和水的乳化劑,因此存在長時間塗抹時持久性下降的問題,並且乳化劑還存在對皮膚造成刺激的問題。 For cosmetics containing powder, when applied to the skin, it improves skin tone and prevents pores, wrinkles, skin problems, etc., while strengthening the skin to a uniform state. Such powder-containing cosmetics can be prepared into a variety of dosage forms. In the case of an emulsifier type, since the emulsifier is used to uniformly disperse oil and water, there is a problem of reduced durability when applied for a long time, and the emulsifier also has a problem Skin irritation.

此外,在無水劑型的情況下,為了提高吸油力而增加揮發性油的含量時,由於劑型不穩定,從而存在劑型分離的問題。 In addition, in the case of an anhydrous dosage form, when the content of volatile oil is increased in order to increase the oil absorption, the dosage form is unstable, which causes the problem of dosage form separation.

因此,要求開發一種吸油力優異的同時,劑型穩定的無水粉末劑型。 Therefore, it is required to develop an anhydrous powder dosage form with excellent oil absorption and stable dosage form.

本發明欲提供一種無水粉末劑型化妝品組合物,所述組合物具有優異的吸油力,因此皮脂吸收力及妝容持久力優異的同時,劑型穩定性優異。 The present invention intends to provide an anhydrous powder formulation cosmetic composition, which has excellent oil absorption and therefore has excellent sebum absorption and makeup lasting power, as well as excellent formulation stability.

本發明提供一種無水粉末劑型化妝品組合物,所述組合物包括矽彈性體凝膠;包含聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物‧二氧化矽的矽彈性體粉末;包含乙烯基聚二甲基矽氧烷/聚甲基矽氧烷矽倍半氧烷交聯聚合物的矽樹脂粉末;矽油;以及矽凝膠劑。 The present invention provides an anhydrous powder-type cosmetic composition. The composition includes a silicone elastomer gel; including polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer•silicon dioxide Elastomer powder; silicone resin powder containing vinyl polydimethylsiloxane/polymethylsiloxane silsesquioxane cross-linked polymer; silicone oil; and silicone gel agent.

本發明的無水粉末劑型化妝品組合物對皮膚所分泌的皮脂、汗等油分的吸收力優異,並且作為無水劑型,沒有使用用於均勻地分散油和水的乳化劑,因此,不會因長時間的塗抹而使持久性降低,並且不對皮膚造成刺激。 The anhydrous powder formulation cosmetic composition of the present invention has excellent absorption of oils such as sebum and sweat secreted by the skin, and as an anhydrous formulation, no emulsifier for uniformly dispersing oil and water is used. The application reduces the durability and does not cause skin irritation.

本發明的無水粉末劑型化妝品組合物可大量含有提高吸油力的矽油,而且不會因大量含有的矽油使劑型分離,因此劑型穩定性優異。 The anhydrous powder formulation cosmetic composition of the present invention can contain a large amount of silicone oil that improves oil absorption, and does not separate the dosage form due to the silicone oil contained in a large amount, so the dosage form stability is excellent.

第1圖是示出將比較例3在55℃下保管3天後,塗抹於皮膚並拍攝的圖。 Figure 1 is a photograph showing that Comparative Example 3 was applied to the skin after storage at 55°C for 3 days.

第2圖是示出將比較例4在55℃下保管14天後,塗抹於皮膚(左側)並拍攝的圖,並示出將比較例5在55℃下保管14天後,塗抹於皮膚(右側)並拍攝的圖。 Figure 2 is a photograph showing that Comparative Example 4 was applied to the skin (left side) after being stored at 55°C for 14 days, and that Comparative Example 5 was applied to the skin after being stored at 55°C for 14 days ( On the right) and photographed.

第3圖是示出將實施例4在55℃下保管14天後,塗抹於皮膚(左側)並拍攝的圖,並示出將實施例6在55℃下保管14天後,將其塗抹於皮膚(右側)並拍攝的圖。 Figure 3 is a photograph showing Example 4 after being stored at 55°C for 14 days, then applied to the skin (left side) and photographed, and showing Example 6 after being stored at 55°C for 14 days and then applied to The skin (right) and the picture taken.

第4圖是示出將比較例2裝入發膏瓶中,並在55℃的溫度下放置3天後,將其取出並暴露於空氣中,然後拍攝劑型的圖。 Figure 4 is a diagram showing that after putting Comparative Example 2 into a hair cream bottle and leaving it at 55°C for 3 days, it was taken out and exposed to the air, and then the dosage form was photographed.

第5圖是示出將實施例6裝入發膏瓶中,並在55℃的溫度下放置3天後,將其取出並暴露於空氣中,然後拍攝劑型的圖。 Figure 5 is a diagram showing that Example 6 was put into a hair cream bottle and left for 3 days at a temperature of 55°C, then taken out and exposed to the air, and then the dosage form was photographed.

本發明提供一種無水粉末劑型化妝品組合物。下面,將對本發明的無水粉末劑型化妝品組合物進行具體說明。 The present invention provides an anhydrous powder dosage type cosmetic composition. Hereinafter, the anhydrous powder-type cosmetic composition of the present invention will be specifically described.

本發明中,對於組合物的各組成成分的含量,在總組成成分的含量的和超過100重量%的範圍內限制其上限。 In the present invention, the upper limit of the content of each component of the composition is limited within the range where the sum of the content of the total component exceeds 100% by weight.

本說明書中提及的化合物的名稱,如果沒有其它特別的說明,則表示符合美國化妝品協會(Cosmetic,Toiletry and Fragrance Association,CTFA)所發行的國際化妝品成分詞典(International Cosmetic Ingredient Dictionary,ICID)中登載的國際化妝品原料(International Nomenclature Cosmetic Ingredient,INCI)命名(Name)的化合物,如果INCI Name中不存在該名稱,則表示根據國際純粹與應用化學聯合會(International Union of Pure and Applied Chemistry,IUPAC)所制定的IUPAC命名法的化合物,如果不存在根據IUPAC命名法的化合物,則表示與本發明的技術領域中通用的化合物的名稱相對應的化合物。 The name of the compound mentioned in this manual, if there is no other special description, it means that it conforms to the International Cosmetic Ingredient Dictionary (ICID) issued by the Cosmetics Association (Cosmetic, Toiletry and Fragrance Association, CTFA) International Nomenclature Cosmetic Ingredient (INCI) name (Name) of the compound, if the name does not exist in the INCI Name, it means that according to the International Union of Pure and Applied Chemistry (International Union of Pure and Applied Chemistry, IUPAC) If there is no compound according to the IUPAC nomenclature in the formulated IUPAC nomenclature, it means the compound corresponding to the name of the compound commonly used in the technical field of the present invention.

本發明中,無水粉末劑型表示組合物不含水。這表示在製備組合物時不添加水,具體而言,根據本發明的化妝品組合物中,相對於組合物總重量,水的含量為10重量%以下。 In the present invention, an anhydrous powder dosage form means that the composition does not contain water. This means that no water is added when preparing the composition. Specifically, in the cosmetic composition according to the present invention, the content of water is 10% by weight or less relative to the total weight of the composition.

1)矽彈性體凝膠 1) Silicone elastomer gel

本發明中,矽彈性體凝膠表示將矽彈性體吸入於矽油中的凝膠,對矽彈性體和矽油的混合量沒有特別的限制。 In the present invention, the silicone elastomer gel means a gel in which silicone elastomer is sucked into silicone oil, and there is no particular limitation on the mixing amount of silicone elastomer and silicone oil.

本發明的一實施方式中,矽彈性體凝膠為選自環聚二甲基矽氧烷‧聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物、環聚二甲基矽氧烷‧聚二甲基矽氧烷交聯聚合物及聚二甲基矽氧烷.聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物中的任意一種或它們的組合。 In one embodiment of the present invention, the silicone elastomer gel is selected from cyclopolydimethylsiloxane‧polydimethylsiloxane/vinylpolydimethylsiloxane cross-linked polymer, cyclopolydimethylsiloxane Methylsiloxane ‧ Polydimethylsiloxane cross-linked polymer and polydimethylsiloxane. Any one or a combination of polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymers.

本發明的一實施方式中,相對於組合物總重量,矽彈性體凝膠的含量為超過0重量%且50重量%以下。 In one embodiment of the present invention, the content of the silicone elastomer gel is more than 0% by weight and less than 50% by weight relative to the total weight of the composition.

2)矽彈性體粉末 2) Silicone elastomer powder

本發明中,矽彈性體粉末包含聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物‧二氧化矽。 In the present invention, the silicone elastomer powder contains polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer ‧ silicon dioxide.

本發明的一實施方式中,相對於組合物總重量,矽彈性體粉末的含量為3~20重量%,較佳為3~10重量%。當矽彈性體粉末的含量少於3重量%時,隨著時間的推移,會分離出油,從而在劑型穩定性方面發生問題,當超過10重量%時,組合物不能凝聚,並且使粉末化,從而不可能形成糊狀物,因此會發生劑型製備方面的問題。相反地,當矽彈性體粉末的含量在3~20重量%的範圍內時,劑型具有流動性,粉末間具有黏滯力,而且劑型不會隨著時間的推移而發生分離或開裂,並且能夠維持穩定的狀態。 In one embodiment of the present invention, relative to the total weight of the composition, the content of the silicone elastomer powder is 3-20% by weight, preferably 3-10% by weight. When the content of the silicone elastomer powder is less than 3% by weight, oil will be separated over time, which will cause problems in the stability of the dosage form. When it exceeds 10% by weight, the composition cannot agglomerate and become powdered , So it is impossible to form a paste, so problems in the preparation of dosage forms may occur. On the contrary, when the content of silicone elastomer powder is in the range of 3-20% by weight, the dosage form has fluidity, the powder has viscous force, and the dosage form will not separate or crack over time, and can Maintain a stable state.

3)矽樹脂粉末 3) Silicone resin powder

本發明中,矽樹脂粉末包含乙烯基聚二甲基矽氧烷/聚甲基矽氧烷矽倍半氧烷交聯聚合物。 In the present invention, the silicone resin powder contains vinyl polydimethylsiloxane/polymethylsiloxane silsesquioxane cross-linked polymer.

本發明的一實施方式中,相對於組合物總重量,矽樹脂粉末的含量為5~25重量%,較佳為5~10重量%。當矽樹脂粉末的含量少於5重量%時,粉末間的黏滯力不足,從而發生製備時不能形成糊狀物的問題,當超過25重量%時,油會從劑型中分離,從而在劑型穩定性方面發生問題。 In one embodiment of the present invention, relative to the total weight of the composition, the content of the silicone resin powder is 5-25% by weight, preferably 5-10% by weight. When the content of silicone resin powder is less than 5% by weight, the viscosity between the powders is insufficient, and the problem of not forming a paste during preparation occurs. When the content exceeds 25% by weight, the oil will separate from the dosage form, resulting in There is a problem with stability.

4)矽油 4) Silicone oil

本發明中,組合物包括矽油,並且因包括矽油,從而被矽彈性體粉末及矽樹脂粉末吸收的矽油在塗抹於皮膚後揮發,因此,矽彈性體粉末及矽樹脂粉末可以有效地吸收皮膚的皮脂、汗等油成分。 In the present invention, the composition includes silicone oil, and because it includes silicone oil, the silicone oil absorbed by the silicone elastomer powder and silicone resin powder evaporates after being applied to the skin. Therefore, the silicone elastomer powder and silicone resin powder can effectively absorb skin Oil components such as sebum and sweat.

本發明的一實施方式中,矽油為選自環五聚二甲基矽氧烷‧環己矽氧烷、聚二甲基矽氧烷‧三矽氧烷及聚二甲基矽氧烷中的任意一種或它們的組合。 In one embodiment of the present invention, the silicone oil is selected from cyclopentadimethylsiloxane‧cyclohexasiloxane, polydimethylsiloxane‧trisiloxane and polydimethylsiloxane Any one or a combination of them.

本發明的一實施方式中,相對於組合物總重量,矽油的含量為40~60重量%。當矽油的含量少於40重量%時,吸油能力不充分,並且粉末間的黏滯力不足,從而發生製備時不能形成糊狀物的問題,當超過60重量%時,油會從劑型中分離,從而在劑型穩定性方面發生問題。 In one embodiment of the present invention, the content of the silicone oil is 40-60% by weight relative to the total weight of the composition. When the content of silicone oil is less than 40% by weight, the oil absorption capacity is insufficient, and the viscosity between the powders is insufficient, so that the problem of not forming a paste during preparation occurs. When it exceeds 60% by weight, the oil will separate from the dosage form , Resulting in problems in dosage form stability.

5)矽凝膠劑 5) Silicone gel

本發明中,組合物包括矽凝膠劑,從而即使含有高含量的矽油,劑型的相也不會發生分離而且使穩定化,並且能夠賦予柔和的使用感。 In the present invention, the composition includes a silicone gel agent, so that even if it contains a high content of silicone oil, the phase of the dosage form will not be separated and stabilized, and it can give a soft feeling of use.

本發明的一實施方式中,矽凝膠劑為聚二甲基矽氧烷/PEG-10/15交聯聚合物‧環五聚二甲基矽氧烷。 In one embodiment of the present invention, the silicone gel agent is polydimethylsiloxane/PEG-10/15 cross-linked polymer ‧ cyclopentadimethylsiloxane.

本發明的一實施方式中,相對於組合物總重量,矽凝膠劑的含量為2~5重量%。當矽凝膠劑的含量少於2重量%時,吸油能力不充分,並且粉末間 的黏滯力不足,從而發生製備時不能形成糊狀物的問題,當超過5重量%時,油會從劑型中分離,從而在劑型穩定性方面發生問題。 In one embodiment of the present invention, relative to the total weight of the composition, the content of the silicone gel is 2 to 5% by weight. When the content of the silicone gel is less than 2% by weight, the oil absorption capacity is insufficient and the powder Insufficient viscous power of the product, resulting in the problem of not forming a paste during preparation. When it exceeds 5% by weight, the oil will separate from the dosage form, causing problems in the stability of the dosage form.

6)其它粉體 6) Other powders

本發明的一實施方式中,組合物可以進一步包括選自二氧化鈦、雲母、聚甲基丙烯酸甲酯、聚甲基矽倍半氧烷、二氧化矽及氧化鈦、氧化鐵、聚甲基丙烯酸甲酯中的任意一種以上的粉體。粉體可以藉由反射光來改善膚色,並且防止毛孔、皺紋、皮膚問題等的同時,吸收皮脂,從而提高妝容的持久性,並且起到將肌膚加強至均勻的狀態等的作用。 In an embodiment of the present invention, the composition may further comprise selected from titanium dioxide, mica, polymethylmethacrylate, polymethylsilsesquioxane, silicon dioxide and titanium oxide, iron oxide, polymethylmethacrylate Any one or more powder of esters. The powder can improve skin tone by reflecting light and prevent pores, wrinkles, skin problems, etc., while absorbing sebum, thereby improving the durability of makeup and strengthening the skin to a uniform state.

本發明的一實施方式中,相對於組合物總重量,粉體的含量為2~25重量%。當粉體的含量少於2重量%時,不貼緊於皮膚,而產生浮粉感的等不利的使用感,當超過25重量%時,會發生製備時不能形成糊狀物的問題。 In one embodiment of the present invention, the content of the powder is 2 to 25% by weight relative to the total weight of the composition. When the content of the powder is less than 2% by weight, it does not adhere to the skin, resulting in unfavorable use feeling such as a floating powdery feeling. When it exceeds 25% by weight, the problem of not forming a paste during preparation may occur.

本發明的一實施方式中,化妝品組合物可以含有化妝品學或皮膚科學上可接受的載體或機制而被劑型化。這些組合物可以根據該領域具有通常知識者的方法製備。 In one embodiment of the present invention, the cosmetic composition may contain a cosmetically or dermatologically acceptable carrier or mechanism to be formulated. These compositions can be prepared according to the method of a person having ordinary knowledge in the field.

此外,本發明的化妝品組合物可以含有諸如常用於化妝品的任何其它成分的在化妝品學或皮膚科學領域中通常使用的輔助劑。輔助劑可以以在化妝品學或皮膚科學領域中通常使用的量來導入。 In addition, the cosmetic composition of the present invention may contain auxiliary agents commonly used in the field of cosmetics or dermatology, such as any other ingredients commonly used in cosmetics. The auxiliary agent can be introduced in an amount generally used in the fields of cosmetics or dermatology.

下面,為了加強對本發明的理解,將藉由實施例、比較例、試驗例等的具體的例子來進行說明。但不能解釋為用下述實施例來限定本發明,並且在本發明的範圍內,本領域技術人員可以進行常規的變化。 Hereinafter, in order to strengthen the understanding of the present invention, specific examples such as examples, comparative examples, and test examples will be used for description. However, it should not be construed as limiting the present invention by the following embodiments, and within the scope of the present invention, those skilled in the art can make conventional changes.

[製備例1]實施例1~5及比較例1的製備 [Preparation Example 1] Preparation of Examples 1 to 5 and Comparative Example 1

根據下述表1的成分,分別製備了實施例1~5及比較例1的組合物,其具體過程如下。 According to the ingredients in Table 1 below, the compositions of Examples 1 to 5 and Comparative Example 1 were prepared, and the specific process is as follows.

Figure 105120624-A0305-02-0008-1
Figure 105120624-A0305-02-0008-1

1)道康寧公司(Dow Corning Corporation)/DC 1-9852矽凝膠(SILICONE GEL) 1) Dow Corning Corporation/DC 1-9852 SILICONE GEL

2)道康寧公司/DC 9040有機矽彈性體混合物(SILICONE ELASTOMER BLEND),聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物(96重量%)及二氧化矽(4重量%) 2) Dow Corning/DC 9040 silicone elastomer blend (SILICONE ELASTOMER BLEND), polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer (96% by weight) and silicon dioxide (4 weight%)

3)金剛化工集團(KCC CORPORATION)/SM9120G(SeraSilk EL 61) 3) King Kong Chemical Group (KCC CORPORATION)/SM9120G (SeraSilk EL 61)

4)道康寧公司/Dow Corning 9701 Cosmetic Powder 4) Dow Corning/Dow Corning 9701 Cosmetic Powder

5)信越化學工業株式會社(Shin-Etsu Chemical Co.,Ltd.)/KSP-101 5) Shin-Etsu Chemical Co., Ltd./KSP-101

6)道康寧公司/PMX-0345矽氧烷混合物(SILOXANE BLEND) 6) Dow Corning/PMX-0345 Silicone Blend (SILOXANE BLEND)

7)道康寧公司/XIAMETER PMX-2127 FLUID 7) Dow Corning/XIAMETER PMX-2127 FLUID

8)信越化學工業株式會社/KSG-240 8) Shin-Etsu Chemical Industry Co., Ltd./KSG-240

9)K.S.PEARL Co.,Ltd./雲母(Sericite)J 9) K.S.PEARL Co.,Ltd./Mica (Sericite) J

10)Negami Chemical Industrial Co.,Ltd./Artpearl K-7P 10) Negami Chemical Industrial Co.,Ltd./Artpearl K-7P

11)邁圖高新材料有限公司(Momentive Performance Materials Inc.)/Tospearl* 2000B 11) Momentive Performance Materials Inc./Tospearl* 2000B

12)JGC C&C/Spherica Microbeads P-1500 12) JGC C&C/Spherica Microbeads P-1500

13)大東化成工業株式會社(DAITO KASEI KOGYO CO.,LTD.)/OTS-2 TIO2 CR-50 13) DAITO KASEI KOGYO CO.,LTD./OTS-2 TIO2 CR-50

14)大東化成工業株式會社/OTS-2 YELLOW LLXLO 14) Daito Chemical Industry Co., Ltd./OTS-2 YELLOW LLXLO

15)大東化成工業株式會社/OTS-2 RED R-516L 15) Daito Chemical Industry Co., Ltd./OTS-2 RED R-516L

16)大東化成工業株式會社/OTS-2 BLACK BL-100 16) Daito Chemical Industry Co., Ltd./OTS-2 BLACK BL-100

使用Primix公司製造的產品名為HIVIS分散攪拌機(Disper Mixer),2P-1的混合機,將成分1及4在常溫(25℃)下混合5分鐘。之後,在成分1及4的混合物中加入成分5及6後,使用混合機,分散5分鐘,在分散過程中控制溫度上升,使溫度控制為50℃以下。 Using a product called HIVIS Disper Mixer (Disper Mixer) manufactured by Primix, a 2P-1 mixer, ingredients 1 and 4 were mixed at room temperature (25°C) for 5 minutes. Then, after adding ingredients 5 and 6 to the mixture of ingredients 1 and 4, use a mixer to disperse for 5 minutes, and control the temperature rise during the dispersion process so that the temperature is controlled to 50°C or less.

在成分1及4~6的混合物中緩緩的投入成分2及3,並使用混合機,分散5分鐘,在分散過程中控制溫度上升,使溫度控制為50℃以下,從而分別製備了實施例1~5及比較例1的組合物。 Slowly put ingredients 2 and 3 into the mixture of ingredients 1 and 4-6, and use a mixer to disperse for 5 minutes. During the dispersion process, the temperature was controlled to rise and the temperature was controlled to 50°C or less to prepare the examples respectively. 1 to 5 and the composition of Comparative Example 1.

[試驗例1]皮脂吸油能力的測定 [Test Example 1] Measurement of sebum oil absorption capacity

當將本發明的化妝品塗抹於皮膚時,矽樹脂粉末、矽彈性體粉末等高吸油性粉末以含有油的狀態被塗抹,因此,剛塗抹之後皮脂吸油能力會降低,然而塗抹後經過一段時間後,揮發成分發生氣化而被釋放,因此,可以使皮脂吸油能力恢復。為了確認此特性,分別將5g的實施例1~5及比較例1的組合物裝入燒杯中,並且在50℃下經過30分鐘後,如下述分別對設定為人工皮脂的辛酸/癸酸甘油三酯(InterMed公司製造、產品名為Imex MCT 60/40)進行濕潤的同時,測定吸油率。 When the cosmetic of the present invention is applied to the skin, high oil-absorbing powders such as silicone resin powder and silicone elastomer powder are applied in a state containing oil. Therefore, the sebum oil absorption capacity will decrease immediately after application, but after a period of time after application , The volatile components are vaporized and released, so the sebum oil absorption capacity can be restored. In order to confirm this characteristic, 5g of the compositions of Examples 1 to 5 and Comparative Example 1 were put into a beaker, and after 30 minutes at 50°C, the caprylic acid/capric acid glycerin set as artificial sebum were treated as follows. Triester (manufactured by InterMed, product name Imex MCT 60/40) was moistened and the oil absorption was measured.

在5g的實施例1~5及比較例1的組合物中,分別緩緩滴入辛酸/癸酸甘油三酯(CAPRYLIC/CAPRIC TRIGLYCERIDE)的同時,測定其重量,並且在該樣品吸收辛酸/癸酸甘油三酯的過程中繼續重複上述操作。當不能繼續吸收辛酸/癸酸甘油三酯時,分別記錄各樣品所吸收的量,並根據下述式1計算皮脂吸油率。 In 5g of the compositions of Examples 1 to 5 and Comparative Example 1, caprylic/capric triglyceride (CAPRYLIC/CAPRIC TRIGLYCERIDE) was slowly dropped, and the weight was measured, and the sample absorbed caprylic/capric triglyceride. Continue to repeat the above operations during the acid triglyceride process. When the absorption of caprylic acid/capric acid triglyceride is not possible, record the absorbed amount of each sample, and calculate the sebum oil absorption rate according to the following formula 1.

[式1]皮脂吸油率(%)=該樣品的辛酸/癸酸甘油三酯(CAPRYLIC/CAPRIC TRIGLYCERIDE)的最終吸收量(單位g)/該樣品的最初重量(5g)×100(%) [Formula 1] Sebum oil absorption rate (%) = the final absorption amount of caprylic/capric triglyceride (CAPRYLIC/CAPRIC TRIGLYCERIDE) of the sample (unit g)/the initial weight of the sample (5g) × 100 (%)

對實施例1~5及比較例1的皮脂吸油率的測定結果如下述表2中所示。 The measurement results of the sebum oil absorption of Examples 1 to 5 and Comparative Example 1 are shown in Table 2 below.

Figure 105120624-A0305-02-0011-2
Figure 105120624-A0305-02-0011-2

如上述表2中所示,可以確認實施例1~5的皮脂吸油率優異,相反,比較例1因劑型分離而不能測定皮脂吸油率。 As shown in Table 2 above, it can be confirmed that the sebum oil absorption rate of Examples 1 to 5 is excellent. On the contrary, in Comparative Example 1, the sebum oil absorption rate cannot be measured due to the separation of the dosage form.

[試驗例2]劑型的穩定度測定 [Test Example 2] Determination of stability of dosage form

將實施例1~5及比較例1分別裝入管容器中後倒立放置,並且在55℃的溫度下放置2周以上後,將其排出並觀察該劑型的狀態。 Examples 1 to 5 and Comparative Example 1 were put into a tube container and placed upside down, and after standing at a temperature of 55°C for more than 2 weeks, they were discharged and the state of the dosage form was observed.

如果根據黏度下降現象而出現單獨分離油或塗抹於皮膚時油被分離到皮膚一側的現象,則將劑型判斷為“分離”,當沒有觀察到這些問題的情況下,則判斷為“穩定”。 If the oil separates separately or the oil is separated to the skin when applied to the skin due to the decrease in viscosity, the dosage form is judged to be "separated", and when these problems are not observed, it is judged to be "stable" .

對實施例1~5及比較例1的劑型分離與否的測定結果如下述表3中所示。 The measurement results of whether the dosage forms of Examples 1 to 5 and Comparative Example 1 are separated are shown in Table 3 below.

Figure 105120624-A0305-02-0011-3
Figure 105120624-A0305-02-0011-3

如上述表3中所示,可以確認根據本發明的組成的實施例1~5的劑型穩定,相反,超出本發明的組成的比較例1的劑型不穩定。 As shown in the above-mentioned Table 3, it can be confirmed that the dosage forms of Examples 1 to 5 according to the composition of the present invention are stable, and on the contrary, the dosage forms of Comparative Example 1 that exceed the composition of the present invention are unstable.

[製備例2]實施例4、6及比較例2~6的製備 [Preparation Example 2] Preparation of Examples 4, 6 and Comparative Examples 2~6

分別製備了實施例4、6及比較例2~6的組合物,對於其具體過程,除了根據下述表4的組成以外,採用了與製備例1相同的製備方法。 The compositions of Examples 4 and 6 and Comparative Examples 2 to 6 were respectively prepared. For the specific process, except for the composition according to the following Table 4, the same preparation method as that of Preparation Example 1 was adopted.

表4

Figure 105120624-A0305-02-0012-4
Table 4
Figure 105120624-A0305-02-0012-4

1)~16):與表1相同。 1)~16): Same as Table 1.

8-1)道康寧公司/DC BY 11-030 8-1) Dow Corning Corporation/DC BY 11-030

8-2)德國贏創工業集團(Evonik)/ABIL EM 90 8-2) Evonik/ABIL EM 90

8-3)信越化學工業株式會社/KF-6038 8-3) Shin-Etsu Chemical Industry Co., Ltd./KF-6038

[試驗例3]劑型的穩定度測定 [Test Example 3] Determination of stability of dosage form

將製備的實施例4、6及比較例3至5的組合物分別填充於管容器中,並且在55℃下保管3天。之後,將保管3天的各組合物塗抹於皮膚上,並進行 拍攝。此外,將這些組合物在55℃下保管14天後,將各組合物塗抹於皮膚上,然後進行拍攝,並且示於第1至3圖中。 The prepared compositions of Examples 4 and 6 and Comparative Examples 3 to 5 were respectively filled in tube containers, and stored at 55°C for 3 days. After that, apply each composition stored for 3 days to the skin and perform Shoot. In addition, after storing these compositions at 55°C for 14 days, each composition was applied to the skin, and then photographed, and these compositions are shown in Figures 1 to 3.

參見第1及2圖,可以確認比較例3(第1圖)、比較例4(第2圖的左側)及比較例5(第2圖的右側)的組合物中,油從劑型分離,因此劑型不穩定。 Referring to Figures 1 and 2, it can be confirmed that in the compositions of Comparative Example 3 (Figure 1), Comparative Example 4 (left side of Figure 2), and Comparative Example 5 (right side of Figure 2), the oil is separated from the dosage form. The dosage form is unstable.

相反地,參見第3圖,可以確認實施例4(第3圖的左側)及實施例6(第3圖的右側)的組合物中,油沒有從劑型分離,因此劑型穩定。 Conversely, referring to Figure 3, it can be confirmed that in the compositions of Example 4 (left side of Figure 3) and Example 6 (right side of Figure 3), the oil is not separated from the dosage form, and therefore the dosage form is stable.

另外,將實施例6及比較例2分別裝入發膏瓶中,並在55℃的溫度下放置三天後,將其取出並暴露於空氣中,然後觀察劑型的表面是否發生開裂現象。 In addition, Example 6 and Comparative Example 2 were respectively put into hair cream bottles, and placed at a temperature of 55° C. for three days, then taken out and exposed to the air, and then observed whether the surface of the dosage form cracked.

參見第4圖,可以確認比較例2如照片所示,觀察到劑型的開裂,因此劑型不穩定。相反地,參見第5圖,可以確認實施例6如照片所示,沒有觀察到開裂的現象,因此劑型穩定。 Referring to Fig. 4, it can be confirmed that in Comparative Example 2, cracking of the dosage form was observed as shown in the photograph, and therefore the dosage form was unstable. On the contrary, referring to Fig. 5, it can be confirmed that in Example 6, as shown in the photograph, no cracking was observed, so the dosage form was stable.

Claims (3)

一種無水粉末劑型化妝品組合物,該組合物包括:一矽彈性體凝膠;包含聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物‧二氧化矽的一矽彈性體粉末;包含乙烯基聚二甲基矽氧烷/聚甲基矽氧烷矽倍半氧烷交聯聚合物的一矽樹脂粉末;一矽油;以及一矽凝膠劑;其中,相對於組合物總重量,該矽彈性體凝膠的含量超過0重量%且50重量%以下,相對於組合物總重量,該矽彈性體粉末的含量為3~20重量%,相對於組合物總重量,該矽樹脂粉末的含量為5~25重量%,相對於組合物總重量,該矽油的含量為40~60重量%,該矽凝膠劑為聚二甲基矽氧烷/PEG-10/15交聯聚合物‧環五聚二甲基矽氧烷,且相對於組合物總重量,該矽凝膠劑的含量為2~4重量%。 An anhydrous powder-type cosmetic composition, the composition comprising: a silicone elastomer gel; a silicone elastomer containing polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer‧silicon dioxide Body powder; a silicone resin powder containing vinyl polydimethylsiloxane/polymethylsiloxane silsesquioxane cross-linked polymer; a silicone oil; and a silicone gel agent; wherein, relative to the combination The content of the silicone elastomer gel is more than 0% by weight and less than 50% by weight, relative to the total weight of the composition, the content of the silicone elastomer powder is 3-20% by weight, relative to the total weight of the composition, The content of the silicone resin powder is 5-25% by weight, relative to the total weight of the composition, the content of the silicone oil is 40-60% by weight, and the silicone gel agent is polydimethylsiloxane/PEG-10/15 Cross-linked polymer ‧ cyclopentadimethylsiloxane, and relative to the total weight of the composition, the content of the silicone gel agent is 2 to 4% by weight. 如請求項1所述之無水粉末劑型化妝品組合物,其中該矽彈性體凝膠為選自環聚二甲基矽氧烷‧聚二甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物、環聚二甲基矽氧烷.聚二甲基矽氧烷交聯聚合物及聚二甲基矽氧烷‧聚二 甲基矽氧烷/乙烯基聚二甲基矽氧烷交聯聚合物中的任意一種或它們的組合。 The anhydrous powder cosmetic composition according to claim 1, wherein the silicone elastomer gel is selected from cyclopolydimethylsiloxane‧polydimethylsiloxane/vinylpolydimethylsiloxane Cross-linked polymer, cyclic polydimethylsiloxane. Polydimethylsiloxane cross-linked polymer and polydimethylsiloxane‧poly two Any one or a combination of methylsiloxane/vinyl polydimethylsiloxane cross-linked polymers. 如請求項1所述之無水粉末劑型化妝品組合物,其中該矽油為選自環五聚二甲基矽氧烷‧環己矽氧烷、聚二甲基矽氧烷‧三矽氧烷及聚二甲基矽氧烷中的任意一種或它們的組合。 The anhydrous powder cosmetic composition according to claim 1, wherein the silicone oil is selected from cyclopentadimethylsiloxane‧cyclohexasiloxane, polydimethylsiloxane‧trisiloxane and poly Any one or combination of dimethylsiloxane.
TW105120624A 2015-06-30 2016-06-29 Anhydrous powder type cosmetic composition TWI705830B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0093767 2015-06-30
KR1020150093767A KR102405999B1 (en) 2015-06-30 2015-06-30 Anhydrous powder type comsmetic composition

Publications (2)

Publication Number Publication Date
TW201707681A TW201707681A (en) 2017-03-01
TWI705830B true TWI705830B (en) 2020-10-01

Family

ID=57608672

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105120624A TWI705830B (en) 2015-06-30 2016-06-29 Anhydrous powder type cosmetic composition

Country Status (5)

Country Link
KR (1) KR102405999B1 (en)
CN (1) CN107979997A (en)
HK (1) HK1254327A1 (en)
TW (1) TWI705830B (en)
WO (1) WO2017003139A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110996899A (en) 2017-07-18 2020-04-10 阿玛特拉苏生命科学有限责任公司 Anti-scuffing gel compositions
KR101944198B1 (en) * 2017-12-18 2019-01-30 김양지 Booklet type color cosmetics classified by 9 types of personal color
CN108542802B (en) * 2018-04-16 2019-07-19 广州市宝琳化妆品有限公司 A kind of transparent muffin of cosmetic and preparation method thereof
KR102321529B1 (en) * 2019-06-17 2021-11-04 코스맥스 주식회사 Anhydrous Eyebrow Make-up Cosmetic Composition
KR20210067243A (en) * 2019-11-29 2021-06-08 (주)아모레퍼시픽 Cosmetic composition for lip
US20220362130A1 (en) * 2021-04-30 2022-11-17 L'oreal Compositions and methods for treating keratin fibers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103371930A (en) * 2012-04-25 2013-10-30 信越化学工业株式会社 Oil-based makeup cosmetic preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100211419B1 (en) 1997-03-14 1999-08-02 서경배 A solid emulsion type cosmetic compositions being applied in T-zone and containing the silicone resin powder
US6475500B2 (en) 2000-07-10 2002-11-05 The Procter & Gamble Company Anhydrous cosmetic compositions
KR101221153B1 (en) 2006-11-27 2013-01-11 (주)아모레퍼시픽 Make-up cosmetic composition of oil-dispersed cake type with high elasticity and the method of preparing thereof
WO2011078407A1 (en) * 2009-12-24 2011-06-30 Dow Corning Toray Co., Ltd. Copolymer having carbosiloxane dendrimer structure, and composition and cosmetic containing the same
KR101269405B1 (en) * 2011-03-11 2013-05-30 코스맥스 주식회사 Make-up cosmetic composition containing silicone elastomer
JP5908699B2 (en) * 2011-10-31 2016-04-26 富士フイルム株式会社 Cosmetics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103371930A (en) * 2012-04-25 2013-10-30 信越化学工业株式会社 Oil-based makeup cosmetic preparation

Also Published As

Publication number Publication date
TW201707681A (en) 2017-03-01
KR102405999B1 (en) 2022-06-08
WO2017003139A1 (en) 2017-01-05
KR20170003291A (en) 2017-01-09
HK1254327A1 (en) 2019-07-19
CN107979997A (en) 2018-05-01

Similar Documents

Publication Publication Date Title
TWI705830B (en) Anhydrous powder type cosmetic composition
JP4757950B2 (en) Lip cosmetic
CN103371930B (en) Oil base cosmetic cosmetic product
KR101815024B1 (en) Stick-shaped cosmetic for moisture replenishment
CZ290905B6 (en) Emulsion base based on water-in-oil emulsion and process for preparing thereof
KR102092335B1 (en) Lip cosmetic composition
US20060067906A1 (en) Extended wear low viscosity cosmetic compositions
KR20130117151A (en) Thermal stable solid formulation of water in oil type emulsion
JP2015124203A (en) Water-in-oil type emulsion cosmetic
JP2017160126A (en) Water-in-oil emulsion cosmetic
KR20210009125A (en) Oil-dispersed cosmetic composition for eye make-up
KR20170088172A (en) Make-up composition of water in oil releasing opaque liquid
TW202011928A (en) Two-layered oil-based cosmetic
JP6644416B2 (en) Composition for suppressing body odor
KR101606776B1 (en) Oily solid-form cosmetic
CN107249563B (en) Compositions and methods for improving the appearance of skin
WO2017212973A1 (en) Antiperspirant or deodorant cosmetic
CN107997991B (en) A kind of essence fluid composition and its application and the cosmetics being made from it
JP6441528B1 (en) Composition for makeup base
JP2015193564A (en) makeup cosmetics
JP6553404B2 (en) Antiperspirant composition
JP2020090478A (en) Oily cosmetic and method for producing oily cosmetic
JP2015124169A (en) Bilayer type powder-containing cosmetic
JP2013194047A (en) Water-in-oil type emulsified cosmetic
KR20130083154A (en) Lip cosmetic composition containing dicaprylyl carbonate

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees